Journalartikel
Autorenliste: Sauerhering, Lucie; Kuznetsova, Irina; Kupke, Alexandra; Meier, Lars; Halwe, Sandro; Rohde, Cornelius; Schmidt, Joerg; Morty, Rory E.; Danov, Olga; Braun, Armin; Vadasz, Istvan; Becker, Stephan; Herold, Susanne
Jahr der Veröffentlichung: 2022
Seiten: 964-968
Zeitschrift: American Journal of Respiratory and Critical Care Medicine
Bandnummer: 205
Heftnummer: 8
ISSN: 1073-449X
eISSN: 1535-4970
Open Access Status: Hybrid
DOI Link: https://doi.org/10.1164/rccm.202108-1830LE
Verlag: American Thoracic Society
Zitierstile
Harvard-Zitierstil: Sauerhering, L., Kuznetsova, I., Kupke, A., Meier, L., Halwe, S., Rohde, C., et al. (2022) Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection, American Journal of Respiratory and Critical Care Medicine, 205(8), pp. 964-968. https://doi.org/10.1164/rccm.202108-1830LE
APA-Zitierstil: Sauerhering, L., Kuznetsova, I., Kupke, A., Meier, L., Halwe, S., Rohde, C., Schmidt, J., Morty, R., Danov, O., Braun, A., Vadasz, I., Becker, S., & Herold, S. (2022). Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection. American Journal of Respiratory and Critical Care Medicine. 205(8), 964-968. https://doi.org/10.1164/rccm.202108-1830LE
